Fast Five Quiz: Non–Small Cell Lung Cancer Management

Daniel S. Schwartz, MD, MBA

Disclosures

February 03, 2021

SBRT may be an option for nonoperative treatment of early-stage lung cancers. Patients best suited for SBRT include those with a peripheral node-negative tumor that is < 5 cm, in whom definitive surgery is contraindicated.

Adjuvant radiation therapy reduces local failures in completely resected (stages II and IIIA) NSCLC but has not been shown to improve overall survival rates. Postoperative radiation therapy for stage I and II lung cancer is currently reserved for cases with positive margins.

Radiation therapy alone is only considered for treatment of stage I and stage II NSCLC when surgical resection is contraindicated owing to limited pulmonary reserve or the presence of comorbidities. Radiation is a reasonable option for the treatment of NSCLC in patients who are not candidates for surgery.

Learn more about radiation therapy for NSCLC.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....